#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia Cerebral amyloid angiopathy Gestational trophoblastic tumour Cold type haemolytic anaemia Acute hepatic failure Anti-HLA antibody test positive Osteosarcoma recurrent Cutaneous T-cell lymphoma stage I Adenoid cystic carcinoma Fungal infection Dermatitis Advanced systemic mastocytosis Demyelination Neurodermatitis Fallopian tube cancer More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Diagnostics Lymphatic malformation – Basic Information Small intestine leiomyosarcoma – Basic Information Familial amyotrophic lateral sclerosis – Basic Information Familial amyotrophic lateral sclerosis Factor VIII deficiency – Trials in Disease Familial amyotrophic lateral sclerosis – Treatment Retinitis pigmentosa – Diagnostics Choroid melanoma – Diagnostics Rhabdomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levoleucovorin Disodium Osimertinib Tx200-Tr101 Ranitidine Vibosameran Io103 Acetate Cefoxitin Pacritinib Iomeprol A/H1N1 INFLUENZA VACCINE L-Lysine Acetate Gskvx000000008885 Mps-200 Lithium Olodaterol Azd5462 AZD5335 Phleum Pratense Dapirolizumab Pegol Ralinepag More therapies…

    Learn about Your Condition

    Lymphocytic leukaemia Agitation postoperative Testicular germ cell cancer Meniscus injury Pharyngeal cancer stage III Skin bacterial infection Low cardiac output syndrome Peritoneal cancer index Lymphangioma Urticaria cholinergic Malignant fibrous histiocytoma Portal hypertension Vulval cancer Myotonia Haemodialysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    Austria Czechia Denmark France Germany Greece +6

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Obefazimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • All-Rac-Alpha-Tocopheryl Acetate Bp
    • Ascorbic Acid Bp
    • Calcium Pantothenate Bp
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Azilsartan Medoxomil
    • Olmesartan Medoxomil
    • Repagermanium
    Czechia Denmark France Germany Italy Portugal +1

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Capecitabine and Durvalumab for Patients with Removed Biliary Tract Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    Investigated Drugs:
    • Capecitabine
    • Durvalumab
    France

  • Study on GSK3858279 for Adults with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Gsk3858279
    France Germany Spain

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Ertapenem
    • Imipenem Monohydrate
    • Temocillin
    France

  • Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    France

  • Study of LY3871801 for Adults with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Ly3871801
    Czechia France Germany Hungary Poland Slovakia
Previous Page
1 … 17 18 19 20 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!